We are live on
!
Find out more
ACM
Accipiter Capital Management Portfolio holdings
AUM
$124M
1-Year Est. Return
6.47%
This Fund
S&P 500
This Quarter
Est. Return
-2.34%
1 Year Est. Return
-6.47%
3 Year Est. Return
-55.92%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$55.8M
AUM Growth
+$1.64M
(+3%)
Cap. Flow
+$1.11M
Cap. Flow
% of AUM
1.99%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
12
New
3
Increased
2
Reduced
4
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FELP
Foresight Energy LP
FELP
|
+$11.5M |
| 2 |
AH
Accretive Health
AH
|
+$6.93M |
| 3 |
THOR
THORATEC CORPORATION
THOR
|
+$5.68M |
| 4 |
Biogen
BIIB
|
+$1.8M |
| 5 |
KND
Kindred Healthcare
KND
|
+$490K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GTS
Triple-S Management Corporation
GTS
|
+$8.94M |
| 2 |
KMP
KINDER MORGAN ENER PNTRS L.P.
KMP
|
+$8.39M |
| 3 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$7.01M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
+$846K |
| 5 |
AT&T
T
|
+$125K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 32.49% |
| 2 | Energy | 19.89% |
| 3 | Industrials | 12.43% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Communication Services | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FELP
1
DELISTED
Foresight Energy LP
FELP
| $11.1M | 19.89% |
+607,563
| New | +$11.5M |
|
|
AH
2
DELISTED
Accretive Health
AH
| $6.93M | 12.43% |
+893,313
| New | +$6.93M |
|
|
BBBY
3
DELISTED
Bed Bath & Beyond Inc
BBBY
| $5.66M | 10.14% |
85,933
-111,411
| -56% | -$7.01M |
|
|
THOR
4
DELISTED
THORATEC CORPORATION
THOR
| $5.35M | 9.59% |
+200,000
| New | +$5.68M |
|
|
KND
5
DELISTED
Kindred Healthcare
KND
| $5.29M | 9.49% |
272,837
+22,499
| +9% | +$490K |
|
|
6
AT&T
T
$164B
| $5.08M | 9.1% |
190,787
-4,702
| -2% | -$125K |
|
|
7
Biogen
BIIB
$30.9B
| $4.96M | 8.9% |
15,000
+5,462
| +57% | +$1.8M |
|
8
Teva Pharmaceuticals
TEVA
$40.4B
| $4.46M | 8% |
83,035
-163
| -0.2% | -$8.64K |
|
9
HP
HPQ
$26B
| $3.55M | 6.36% |
220,200
| – | – |
|
|
10
BioMarin Pharmaceuticals
BMRN
$11.9B
| $3.4M | 6.1% |
47,120
-12,880
| -21% | -$846K |
|
|
GTS
11
DELISTED
Triple-S Management Corporation
GTS
| – | – |
-524,346
| Closed | -$8.94M |
|
|
KMP
12
DELISTED
KINDER MORGAN ENER PNTRS L.P.
KMP
| – | – |
-102,115
| Closed | -$8.39M |
|
Similar funds
ACM
MCM
TCM
ALIONA
HA
DFIG
PAM
KC
Accipiter Capital Management's Q3 2014 Portfolio in Review
As of Q3 2014, Accipiter Capital Management held 12 positions worth $55.8M, up 3% from $54.1M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Accipiter Capital Management's Q3 2014 filing shows 3 new, 2 increased, 4 reduced and 2 closed positions. Its largest new stake was Foresight Energy LP: 607,563 shares worth $11.1M. The largest sale was Triple-S Management Corporation, an estimated $8.94M.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 31% a quarter earlier, followed by Energy and Industrials.
- Accipiter Capital Management's largest Q3 2014 buy was Foresight Energy LP: 607,563 shares worth $11.1M.
- Accipiter Capital Management added most to Biogen in Q3 2014, an estimated $1.8M increase.
- Accipiter Capital Management's biggest Q3 2014 reduction was Bed Bath & Beyond Inc, cutting an estimated $7.01M.
- Accipiter Capital Management fully exited Triple-S Management Corporation in Q3 2014, selling an estimated $8.94M.
- Accipiter Capital Management's ten largest holdings make up 100% of its $55.8M portfolio in Q3 2014.
- Accipiter Capital Management opened 3 new positions and closed 2 in Q3 2014.
- Accipiter Capital Management's portfolio value rose 3% quarter-over-quarter to $55.8M.
Based on Accipiter Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.